Overview
Heartland Bridge Capital, Inc. (“HBC”) is a newly organized public company (OTCBB: HLBC) that intends to serve the financial and other needs of emerging companies run by exceptionally talented entrepreneurs and operating executives who are dedicated to creating positive change in our world. HBC will have operating assets, but also function as a holding and investment company, broadly akin to Berkshire Hathaway or other private equity firms, focused primarily on providing equity, acquisition debt, or bridge financing to emerging high-growth companies and entrepreneurs. Additionally, HBC may supplement the capabilities of the companies in which it invests in non-financial areas to help them achieve their potential, thereby maximizing the value of the investment for HBC’s shareholders.
HBC’s investment focus will be on companies that provide a social benefit aimed directly and tangibly at making people’s lives better. HBC’s primary interest will be in four technology areas: Nanotech, Medical Technology, Clean Energy Technologies (including alternatives and renewables), and Waste Management Technology.
HBC has a distinct advantage relative to most other similar companies: HBC does not have the burden of having to deal with – from both a financial and a managerial perspective – the challenges resulting from having made investments during the inflated valuation environment of 2005 to 2007. Instead, HBC has the opportunity to benefit from the depressed market of today – and history shows that private equity investments made during times of market distress have produced the best returns. Oft-quoted, Baron Rothschild, an 18th century British nobleman and member of the Rothschild banking family, is credited with saying that: “The time to buy is when there's blood in the streets.” There is a view that the current “great recession” has put virtual blood in the streets, potentially offering exceptional investment opportunities.
HBC intends to offer investors a means to participate in investments with the potentially attractive risk/reward profiles sought by hedge funds but at an investment level that is manageable for the everyday investor. By committing to maintain its share price at a level that is easy for most investors to purchase, the pool of participants will be “inclusive” rather than “exclusive” – thus achieving one of the primary goals of the founders of HBC.
Management
James F. Groelinger is the Chairman, President, and Chief Executive Officer of HBC. Jim has extensive international corporate and business management experience with a strong focus on business development and value creation in all aspects of the energy field.
Since 2007, Mr. Groelinger has been the Managing Director at Bellegrove Associates where he provides strategic guidance to emerging clean energy entrepreneurs and companies. This guidance includes evaluating potential energy-related investments, and assisting inventors with the commercialization of energy-related patents and products. Since 2009, Mr. Groelinger has also been the Executive Director of the Clean Energy Alliance, Inc., a national association of clean energy incubators.
From 2001 to 2006, Mr. Groelinger was the Chief Executive Officer and a Director, and was President from 2007 to 2008, of EPV Solar, Inc., a photovoltaic module technology company that developed and marketed a proprietary technology for the production of thin-film photovoltaic products. As CEO, Mr. Groelinger led the company and oversaw sales as they increased from nil to more than $20 million annually, developed products sales in the U.S., Germany, and Spain, oversaw joint ventures with foreign manufacturers, and managed a complex $60 million debt-for-equity recapitalization, setting the stage for a $70 million third-party financing and initial public offering.
In the ‘90s, through his own transaction-oriented consulting firm, Jim provided investment and strategic advisory services to companies wanting to participate in the domestic and international private power industry. Earlier, he was a Director of Putnam, Hayes & Bartlett, Inc., a strategy advisory firm in which he provided project finance and evaluation expertise with an emphasis on electric utilities, private power, and the development of competition..
Jim has an MBA-Finance from Temple University and a Bachelors in Chemical Engineering from City College of New York.
Frederick Larcombe is HBC’s Chief Financial Officer. Frederick has more than thirty years of diversified experience in life sciences, medical devices, entertainment, manufacturing, and professional services. He is experienced in raising capital, strategic planning and analysis, operating company management, intellectual property litigation, re-organization and turn-around situations, business acquisition and integration, SEC reporting, and investor relations.
Fred also serves as Chief Financial Officer for iBio, Inc., a public biopharmaceutical company, and The Ride, a venture-backed entertainment company. He has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer. He started his professional career with PriceWaterhouseCoopers (PwC).
Fred received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.
Frederick A. Voight is the Managing Director of Investments for HBC. Fred has been the Managing Director of F.A. Voight & Associates LP, which has made investments in numerous companies and products, since its inception in 1994. Mr. Voight has more than twenty years of experience in managing these types of investments. He has previous experience as the Chairman and CEO of a public company and has served as a director of several public and numerous private companies.
Bruce Glasser is HBC’s Director of Investment Banking. Bruce has participated in dozens of Private Equity and Venture Capital transactions. He has interacted and developed relationships with hundreds of Institutional Investors, including Hedge Funds, Venture Capital Funds, Private Equity Funds, and Senior and Subordinated Debt Lenders.
Wayne LeBlanc is HBC’s Senior Managing Director, Business Development. He has over 25 years of diverse experience in sales and marketing in both large and small businesses, specializing in conducting evaluations and needs analyses for new or increased market penetration. He has extensive experience in the fields of electricity, clean and renewable energy, and medical devices, all of which fit in well with the business strategy of HBC.
Advisory Board
In addition to the direct management, an Advisory Board is being organized and will comprise experts in each of the business sectors of primary interest to HBC. The Advisory Board will provide HBC’s management with independent and informed views of industry trends, and will recommend and review investment opportunities, both prior to an investment and in the course of managing the investment once it has been made.
News 
Market Data 
Discover 
